Sign in or Register   Sign in or Register
  |  

Mouse Anti-AHNAK2 Recombinant Antibody (V2-611044) (CBMAB-A0197-LY)

The product is antibody recognizes AHNAK2. The antibody 4G9 immunoassay techniques such as: WB, ELISA.
See all AHNAK2 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
V2-611044
Antibody Isotype
IgG2a, κ
Application
WB, ELISA

Basic Information

Immunogen
AHNAK2 (XP_290629.5, 5527 a.a. ~ 5636 a.a) partial recombinant protein with GST tag.
Host Species
Mouse
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Liquid
Buffer
PBS, pH 7.4
Preservative
None
Concentration
Batch dependent
Purity
> 95% Purity determined by SDS-PAGE.
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
AHNAK nucleoprotein 2
Entrez Gene ID
113146
Alternative Names
C14orf78; KIAA2019
Biological Process
Regulation of RNA splicing
Cellular Location
Nucleus

Lin, Q. Y., Qi, Q. L., Hou, S., Chen, Z., Jiang, N., Zhang, L., & Lin, C. H. (2021). Silencing of AHNAK2 restricts thyroid carcinoma progression by inhibiting the Wnt/β-catenin pathway. Neoplasma.

Zheng, M., Liu, J., Bian, T., Liu, L., Sun, H., Zhou, H., ... & Liu, Y. (2021). Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma. International Immunopharmacology, 90, 107134.

Zheng, L., Li, S., Zheng, X., Guo, R., & Qu, W. (2021). AHNAK2 is a novel prognostic marker and correlates with immune infiltration in papillary thyroid cancer: Evidence from integrated analysis. International Immunopharmacology, 90, 107185.

Wang, D. W., Zheng, H. Z., Cha, N., Zhang, X. J., Zheng, M., Chen, M. M., & Tian, L. X. (2020). Down-regulation of AHNAK2 inhibits cell proliferation, migration and invasion through inactivating the MAPK pathway in lung adenocarcinoma. Technology in Cancer Research & Treatment, 19, 1533033820957006.

Zhang, S., Lu, Y., Qi, L., Wang, H., Wang, Z., & Cai, Z. (2020). AHNAK2 is associated with poor prognosis and cell migration in lung adenocarcinoma. BioMed Research International, 2020.

Xie, Z., Lun, Y., Li, X., He, Y., Wu, S., Wang, S., ... & Zhang, J. (2020). Bioinformatics analysis of the clinical value and potential mechanisms of AHNAK2 in papillary thyroid carcinoma. Aging (Albany NY), 12(18), 18163.

Li, M., Liu, Y., Meng, Y., & Zhu, Y. (2019). AHNAK nucleoprotein 2 performs a promoting role in the proliferation and migration of uveal melanoma cells. Cancer biotherapy & radiopharmaceuticals, 34(10), 626-633.

Lu, D., Wang, J., Shi, X., Yue, B., & Hao, J. (2017). AHNAK2 is a potential prognostic biomarker in patients with PDAC. Oncotarget, 8(19), 31775.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-AHNAK2 Recombinant Antibody (V2-611044)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare